1 Institute for Molecular Bioscience, 2 Department of Biochemistry, and 3 Department of Physiology and Pharmacology, University of Queensland, Brisbane 4072, Queensland, Australia
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
E-cadherin is a major component of
adherens junctions in epithelial cells. We showed previously that a
pool of cell surface E-cadherin is constitutively internalized and
recycled back to the surface. In the present study, we investigated the
potential role of protein kinase C (PKC) in regulating the trafficking
of surface E-cadherin in Madin-Darby canine kidney cells. Using surface biotinylation and immunofluorescence, we found that treatment of cells
with phorbol esters increased the rate of endocytosis of E-cadherin,
resulting in accumulation of E-cadherin in apically localized early or
recycling endosomes. The recycling of E-cadherin back to the surface
was also decreased in the presence of phorbol esters. Phorbol
ester-induced endocytosis of E-cadherin was blocked by specific
inhibitors, implicating novel PKC isozymes, such as PKC- in this
pathway. PKC activation led to changes in the actin cytoskeleton
facilitating E-cadherin endocytosis. Depolymerization of actin
increased endocytosis of E-cadherin, whereas the PKC-induced uptake of
E-cadherin was blocked by the actin stabilizer jasplakinolide. Our
findings show that PKC regulates vital steps of E-cadherin trafficking,
its endocytosis, and its recycling.
trafficking; cell-cell adhesion; actin
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
ADHERENS JUNCTIONS on the lateral surfaces of epithelial cells mediate cell-cell contact and have a central role in establishing and maintaining cell polarity. Members of the cadherin superfamily function as primary mediators of Ca2+-dependent cell-cell adhesion, linking adjacent cells through homophilic binding of cadherin ectodomains (16). E-cadherin subserves this key adhesion role in epithelial cells. Cadherin-mediated adhesion must be dynamic to accommodate epithelial growth and remodeling during development and for wound healing and turnover of epithelia in mature tissues (17, 44, 46). Cell-cell adhesion in epithelia is disrupted during tumorigenesis, where the loss of cadherin function augurs transformation to a metastatic phenotype (20).
The adhesive strength of cell-cell contacts depends on factors such as
dimerization and lateral clustering of cadherin molecules (39,
47). Cadherins also form high-affinity complexes with catenins
and other molecules, which participate in the overall function and
stability of the adherens junctions (34). E-cadherin is
bound to -catenin and thence to
-catenin, which links the complex
to the actin cytoskeleton (25, 34, 38). Cadherin-catenin complexes form detergent-resistant plaques when bound stably to actin
cables at the points of cell-cell contact (2, 33). Tracking of fluorescence-tagged E-cadherin in forming epithelial monolayers revealed the dynamic nature of the cadherin complexes associated with circumferential actin during contact formation and
compaction (1). Rho family GTPases
Rho, Rac, and
Cdc42
produce different configurations of actin in cells
(18) and have been implicated in remodeling actin for
regulation of cell-cell contacts. Expression of constitutively active
Rac1 accumulates cadherins, catenins, and actin at junctions, resulting
in E-cadherin-mediated adhesion in both mammalian cells and
Drosophila (9, 12, 37). The actin cytoskeleton
therefore has roles in stabilizing cell-cell contacts and also perhaps
in more dynamic movement of cadherins in and out of adherens junctions.
The trafficking of E-cadherinits delivery to or removal from the cell
surface
is one aspect of cadherin biology that is not yet thoroughly
understood. There is a growing body of evidence to show that cell
surface E-cadherin can be endocytosed and trafficked back into the
cell. A variety of studies have shown that cadherins are internalized
after the disruption of junctions, for instance, by Ca2+
depletion (4, 6, 22, 23). In a previous study we
(26) also established, importantly, that E-cadherin
undergoes endocytosis and recycling in Madin-Darby canine kidney (MDCK)
cell monolayers under physiological conditions. The adhesive strength
at cell-cell contacts depends, in part, on the amount of E-cadherin at
the cell surface (47). On the basis of the finding that
recycling of internalized E-cadherin is required to form cell-cell
contacts (26), we proposed that such a recycling pathway
provides one mechanism for dynamically regulating cadherin-based
adhesion, by balancing the relative amounts of surface-exposed and
sequestered intracellular E-cadherin. Such a mechanism has, in fact,
been recorded during gastrulation in sea urchin embryos, where
E-cadherin is seen to move in and out of the cell to accommodate
epithelial-mesenchymal conversions (29). Parallel pathways
also exist for the endocytosis and recycling of integrins and thereby
for the regulation of integrin-based contact with substrata
(32). Recycling might thus be a common means of regulating
adhesion at the cell surface. How the endocytosis and recycling of
E-cadherin are regulated is therefore of prime importance to the
control of cell-cell adhesion.
The protein kinase C (PKC) family of serine-threonine protein kinases includes multiple isoforms, or isozymes, which are classified into three main groups, conventional, novel, or atypical, depending on their requirements for Ca2+ and diacylglycerol (30). Phorbol 12-myristate 13-acetate (PMA) is a well-known tumor-promoting phorbol ester and a commonly used activator of conventional and novel forms of PKC. The PKC family is ubiquitous, and individual isozymes have been broadly implicated in many cell functions, including cytoskeletal rearrangements, membrane traffic, ion transport, and cell adhesion (24, 31). PKC has demonstrated roles in regulating endocytosis (21, 41, 43). PKC has been implicated in signaling events that control the internalization of several cell surface receptors, usually via clathrin-mediated pathways, and in other pathways such as phagocytosis (27) and the uptake of fluid phase markers. The use of phorbol esters to activate PKC produces disparate effects in different cell types and even reveals independent mechanisms for regulating endocytosis at the apical or basolateral membrane domains of polarized cells. PMA activation of PKC in T84 cells increased basolateral, but not apical, uptake of fluid phase markers (43), whereas, in MDCK cells, phorbol esters increased both fluid phase uptake and clathrin-mediated uptake from the apical but not basolateral membrane (21, 41). PKC activation also stimulated transcytosis and delivery of receptors to the apical membrane in MDCK cells (10).
In the present study, regulation of the endocytosis and recycling of E-cadherin in confluent MDCK cells under physiological conditions was investigated. Novel findings are presented to show that the bidirectional movement of E-cadherin between the cell surface and endosomes is regulated and that PKC and actin are implicated in this regulation. This is the first demonstration that two linked trafficking steps of E-cadherin are regulated by PKC in a fashion poised to regulate cadherin function at the cell surface.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell culture. MDCK cells (strain II) were grown and passaged as previously described in DMEM (Life Technologies, Grand Island, NY) with 10% FCS and 2 mM glutamine in 5% CO2-95% air (26). Cells used in experiments were plated at confluent density on semipermeable polycarbonate filters (Transwell; Corning Costar, Cambridge, MA) or plated onto glass coverslips and maintained for 1-3 days before being used. For most experiments, cells were incubated in medium containing 10 µM cycloheximide to block protein synthesis to clear newly synthesized E-cadherin, leaving only endocytosed E-cadherin as the intracellular pool. Cells were incubated in medium containing 0.1 µM PMA to induce PKC activation (11). The PKC inhibitor bisindolylmaleimide (Gö-6850; Calbiochem, CA) or the indolocarbazole PKC inhibitor (Gö-6976; Calbiochem, CA) was added at 5 µM (final concentration) to culture medium for various times at 37°C. In some experiments, cells were incubated in medium containing 1 µM jasplakinolide (Jas; Molecular Probes, Eugene, OR) or in medium containing 10 µM cytochalasin D (CyD; Sigma, St. Louis, MO) before processing.
Antibodies.
A mouse E-cadherin antibody (3B8) raised against MDCK E-cadherin was
used for immunofluorescence experiments. For immunoblotting, we
used a mouse monoclonal antibody against human E-cadherin (Transduction Laboratories, Lexington, KY). Other primary antibodies used included mouse monoclonals against -catenin and
-catenin (Transduction Laboratories) and a mouse monoclonal antibody directed against
-actin (a gift of Dr. R. Weinberger, New Children's Hospital, Westmead, Australia). Secondary antibody conjugates used were sheep
anti-mouse IgG-Cy3 (Jackson Immunoresearch Labs, West Grove, PA), goat
anti-mouse IgG-Alexa 488 (Molecular Probes), and horseradish peroxidase-labeled sheep anti-mouse IgG (Amrad Laboratories).
Immunofluorescence staining. Cells were fixed in 4% paraformaldehyde in PBS for 90 min and then permeabilized for 5 min in PBS containing 0.1% Triton X-100. Cells were incubated with primary antibodies followed by incubation in secondary antibodies with PBS containing BSA as a blocking buffer. Cells were mounted in 50% glycerol-1% n-propyl gallate in PBS and viewed by epifluorescence on an Olympus Provis X-70 microscope. Images were collected with an CCD300ET-RCX camera using NIH image software. Cells grown on Transwell filters were examined with a Bio-Rad MRC-600 confocal laser scanning microscope, and X-Y and X-Z sections were generated with Bio-Rad MRC-600 cmos software.
Fluid-phase endocytosis. Rhodamine-dextran (lysine-fixable, anionic rhodamine-conjugated dextran, molecular weight 10,000; Molecular Probes) was added to the medium in upper or lower chambers of Transwell units and used to measure fluid phase uptake from the apical or basal side of monolayers. After various times at 37°C, cells were placed on ice and washed three times with ice-cold serum-free medium, followed by fixation and mounting on coverslips for confocal microscopy. In some experiments, cells were also fixed and double labeled with E-cadherin antibodies.
Cell surface biotinylation. MDCK cells grown on filters were incubated on ice for 1 h with 1.5 mg/ml sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate (sulfo-NHS-SS-biotin; Pierce, Rockford, IL) applied to the basal side of the filter, followed by washing with sulfo-NHS-SS-biotin blocking reagent (50 mM NH4Cl in PBS containing 1 mM MgCl2 and 0.1 mM CaCl2) to quench free sulfo-NHS-SS-biotin, followed finally by several further washes in PBS. Cells were then scraped off filters and lysed in 500 µl of RIPA buffer (25 mM Tris · HCl pH 7.4 with 150 mM NaCl, 0.1% SDS, 1% Triton X-100, and 1% deoxycholate) with protease inhibitors (Roche Molecular Biochemicals, Mannheim, Germany). Cell extracts were centrifuged, and the supernatants were incubated with streptavidin beads (Sigma) to collect biotinylated proteins, which were then analyzed by SDS-PAGE and immunoblotting to identify E-cadherin. Staining of transfer membranes with 0.1% Coomassie brilliant blue ensured even protein transfer and protein loading. Proteins detected by immunoblotting were visualized with chemiluminescence (Pierce). Different luminescence exposures were collected, and exposures in the linear range were used.
Biotinylation assay for endocytosis and recycling.
Surface biotinylation was adapted to measure the endocytosis of
E-cadherin as described previously (26). Confluent MDCK cells grown on Transwell filters were pretreated with cycloheximide and
biotinylated at 0°C, followed by washing and quenching of free
biotin. The cells were then incubated in culture medium at 37°C for
various times to allow uptake. Monolayers were then glutathione stripped as originally described by Graeve et al. (15) by
incubation in two 20-min washes of glutathione solution (50 mM
glutathione, 75 mM NaCl, 75 mM NaOH, and 1% BSA) at 0°C, which
removed all cell surface biotin groups. The effectiveness of
glutathione stripping at removing all biotinyl groups from surface
proteins was demonstrated in cells surface-biotinylated at 0°C for
1 h followed immediately by glutathione stripping. No E-cadherin
was recovered with streptavidin beads from these samples in the
recovered biotinylated fraction (e.g., see Fig. 1A,
lane 2). The remaining biotinylated proteins, sequestered
inside cells after endocytosis, were protected from glutathione
stripping and were collected on streptavidin beads and analyzed by
immunoblotting. In some experiments cells were incubated at 18°C to
accumulate internalized E-cadherin (26).
|
Immunoprecipitation. Confluent monolayers of MDCK cells were solubilized in cold RIPA buffer containing protease inhibitors on ice. RIPA-soluble cell extracts were obtained by centrifugation and incubated with E-cadherin antibody for 90 min and then with washed protein A Sepharose beads (Pierce) for a further 90 min. Precipitates were recovered by centrifugation and then washed several times with RIPA buffer and 20 mM Tris · HCl pH 7.4 before solubilization in concentrated SDS-PAGE sample buffer. Bound E-cadherin and actin were then analyzed by SDS-PAGE and immunoblotting.
Cell fractionation. Confluent monolayers of cells were scraped into ice-cold homogenization buffer (1 mM EDTA, 10 mM Tris pH 7.4, containing protease inhibitors). Cells were lysed by repeated passage through a 27.5-G needle. Nuclei and unbroken cells were removed by low-speed centrifugation. The resulting postnuclear supernatant was ultracentrifuged at 100,000 g for 90 min. The pellet constituting the total microsomal membrane fraction was resuspended in homogenization buffer. The supernatant was recentrifuged at 100,000 g for 45 min to finally remove membranes, and this supernatant was collected as the cytosol fraction. Protein concentrations of the membranes and cytosol were determined with the bicinchoninic acid (BCA) protein assay kit (Pierce). Membrane and cytosol fractions were analyzed by SDS-PAGE and immunoblotting.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Accumulation of intracellular E-cadherin in PMA-treated MDCK cells. We previously established (26) a biotinylation assay for measuring the internalization of surface-biotinylated E-cadherin in confluent MDCK cell monolayers. At steady state, relatively small but uniform amounts of E-cadherin are endocytosed (Fig. 1A, lane 1) and are measured as a pool of biotinylated E-cadherin that remains sequestered after stripping cell surface biotin (Fig. 1A, lane 3). In all experiments, cells are pretreated with cycloheximide to ensure that all E-cadherin in the biosynthetic pathway is cleared, leaving endocytosed E-cadherin as the only intracellular pool. In these experiments, cells were treated with a phorbol ester (PMA) at a range of concentrations (1 nM-1 µM) to activate PKC and then assayed for E-cadherin endocytosis. Cells incubated in the presence of PMA displayed a progressive, dose-dependent increase in the amount of internalized E-cadherin (Fig. 1A, lanes 4-7). PMA at 0.1 µM induced maximal sequestration of internalized E-cadherin (>4-fold increase over control cells; Fig. 1). At higher concentrations of PMA (1-10 µM) the amount of internalized E-cadherin was reduced, consistent with the downregulation of PKC often observed with prolonged exposure or at high concentrations of PMA (10).
The uptake of surface-biotinylated E-cadherin was then followed over a time course in the presence or absence of 0.1 µM PMA (Fig. 2A). In control cells a small, constitutive pool of surface-biotinylated E-cadherin was internalized, and this remained constant over time, as a result of recycling (Ref. 26; Fig. 2A, lanes 3-6). In contrast, in PMA-treated cells, the size of the intracellular pool of E-cadherin increased over time (Fig. 2A, lanes 7-10), so that by 60 min, there was a greater than fivefold accumulation of intracellular E-cadherin (Fig. 2A, lanes 7-10). The increased accumulation of E-cadherin by PMA was also seen in cells incubated at 18°C, which itself serves to accumulate endosomal E-cadherin (26). As seen in Fig. 2B, PMA-treated cells displayed a more rapid accumulation of internalized E-cadherin during the first 30 min, resulting in a larger internal pool of E-cadherin after 60 min (Fig. 2B, lanes 7 and 8). Thus PMA treatment enhances the uptake of surface E-cadherin; this increased uptake contributes to a greater and progressive accumulation of E-cadherin in internal endosomes.
|
Selective PKC inhibition retards PMA-induced E-cadherin
endocytosis.
Phorbol esters are known to have their effects by acting on multiple
targets and signaling pathways. To establish whether the effects of PMA
on E-cadherin endocytosis are working primarily through PKC, we used
PKC inhibitors to abrogate the effects of PMA in the biotinylation
assay. The uptake of surface-biotinylated E-cadherin in PMA-treated
cells was measured over 90 min at 37°C in the presence of specific
PKC inhibitors, Gö-6850 (5 µM), which acts to inhibit both
conventional and novel PKC isoforms by competing for ATP binding sites
(14, 45), and Gö-6976, which is a more selective
inhibitor for the conventional PKC isoforms (28). Cells
incubated in the presence of PMA alone showed a progressive increase in
internalized E-cadherin; addition of Gö-6850 significantly reduced internalization throughout the time course. Cells incubated in
the presence of Gö-6850 alone or with PMA plus Gö-6850 did not accumulate E-cadherin intracellularly over 90 min, showing that
this inhibitor blocked the effect of PMA (Fig.
3, A and C). The
other inhibitor, Gö-6976, had no such effect and did not alter
the PMA-induced accumulation of intracellular E-cadherin (Fig. 3,
B and C). The selective abrogation of PMA-induced
uptake by Gö-6850, but not by Gö-6976, implicates the novel
class of PKC isozymes in this regulation. Additional PKC isoforms or
other regulators may also affect E-cadherin internalization because Gö-6850 produced an incomplete block of PMA activity in this assay.
|
PMA inhibits recycling of endocytosed E-cadherin.
To test the influence of PMA on the recycling of surface E-cadherin,
the exit of internalized, surface-biotinylated E-cadherin back to the
cell surface was measured (Fig.
4A). Cells were
surface-biotinylated at 0°C and then incubated at 18°C for 60 min
to accumulate internalized, labeled E-cadherin. After glutathione
stripping, cells were returned to 37°C to resume trafficking in the
presence or absence of PMA for various periods (0-30 min). Cells
were then sequentially treated with glutathione at each chase time to
remove biotinyl groups from endocytosed proteins as they returned to
the cell surface. The remaining unrecycled, biotinylated proteins at
each time point were recovered and immunoblotted for E-cadherin. The
amount of internalized E-cadherin accumulated in control cells at
18°C progressively decreased as cells were rewarmed to 37°C to
allow recycling (Fig. 4A, lanes 3-6), so
that by 30 min the majority (90%) of internal E-cadherin had returned
to the cell surface and was stripped (Fig. 4A, lane
6). In contrast, PMA-treated cells displayed a much slower decrease in the internal pool of E-cadherin throughout the release period, with ~40% of the accumulated pool still remaining after 30-min treatment with PMA (Fig. 4A, lane 10).
These results show that PMA retards E-cadherin release from endosomes.
|
PMA increases uptake of E-cadherin into apical recycling endosomes.
The effect of PMA on the distribution of E-cadherin in fixed,
filter-grown MDCK cells was studied by confocal microscopy. At steady
state, E-cadherin in confluent MDCK cells is localized mostly at the
lateral cell surface with minimal staining in small intracellular
vesicles (Fig. 5, see also Fig.
4C; Ref. 26). PMA treatment (30 min) produced
significantly more vesicular staining of E-cadherin than in untreated
cells, with no discernable change in the level of cell surface staining
(Fig. 5, a and b). Intracellular E-cadherin in
PMA-treated cells was localized in more numerous and larger structures,
which were found in X-Z image views to be located near the
apical cell surface (Fig. 5d). Increased intracellular staining is thus consistent with increased endocytosis of surface E-cadherin in the presence of PMA.
|
Depolymerization of F-actin is required for E-cadherin endocytosis.
Actin-binding proteins are commonly implicated as downstream effectors
of PKC and are also known to be involved in endocytosis. Experiments
were carried out to examine the role of actin polymerization in
PKC-regulated E-cadherin trafficking. The uptake of
surface-biotinylated E-cadherin was measured in the presence of the
drugs CyD and Jas, which act to prevent actin polymerization and to
stabilize F-actin, respectively (42). Treatment with CyD
alone significantly enhanced the internalization of E-cadherin above
controls to ~80% of the levels obtained with PMA (Fig.
6). Preincubation of cells with CyD and
PMA together did not produce an additive effect. Stabilization of
F-actin with Jas alone had no effect on E-cadherin uptake; however,
pretreatment with Jas fully abrogated the subsequent PMA response,
resulting in only control levels of E-cadherin uptake (Fig. 6).
Immunofluorescence staining for E-cadherin also confirmed that
preincubation of cells with Jas blocked the accumulation of E-cadherin
in apical endosomes, which were otherwise present in cells treated with
PMA alone (Fig. 7). Because Jas competes with the binding sites for phalloidin (42), the F-actin
changes accompanying these treatments could not be demonstrated in
stained cells. Together these results show that PMA is acting
largely or wholly through actin to regulate the uptake of E-cadherin. Moreover, depolymerization of F-actin is required for endocytosis induced by PMA.
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We have shown that both the endocytosis of cell surface E-cadherin and its recycling back to the cell surface are regulated events. Treatment of cells with the phorbol ester PMA increased the uptake of surface-biotinylated E-cadherin and decreased its recycling back to the cell surface, suggesting that PMA affects at least two transport steps. The net effect was a PMA-induced intracellular accumulation of surface E-cadherin, which was demonstrated by two independent methods: 1) the sequestration of increased amounts of surface-biotinylated E-cadherin and 2) increased staining of E-cadherin in endosomal compartments in PMA-treated cells. In several experiments, results obtained with the biotinylation assay were consistent with the finding that PMA increased either the rate or volume of E-cadherin endocytosis, which contributed to an accumulating intracellular pool instead of maintaining the relatively small steady-state level of intracellular E-cadherin. PMA produced a substantial increase (>4-fold) in the amount of E-cadherin sequestered inside cells, supporting the concept that PKC might play a significant role in regulating E-cadherin function and cell adhesion.
The use of specific PKC inhibitors verified that PMA is acting
primarily through PKC to have its effect on E-cadherin trafficking. There are multiple phorbol ester-sensitive isozymes of PKC, all of
which have pleiotropic distributions and functions in different cell
types (30). The inhibitor Gö-6850 was found to
largely block PMA-induced endocytosis in the biotinylation assay and
the exit of E-cadherin from endosomes. Gö-6850 inhibits novel
class, Ca2+-independent PKC isozymes, and immunoblotting of
MDCK fractions revealed the presence and membrane translocation of
PKC- as a possible candidate for the regulation of both endo- and
exocytosis of E-cadherin. Although our studies do not provide specific
evidence to implicate PKC-
as a regulator in E-cadherin recycling,
it has been implicated in other trafficking pathways such as the endocytosis of fluid phase markers in polarized T84 cells
(43) and in transcytosis in MDCK cells (10).
Two independent steps of E-cadherin traffickingits internalization
into endosomes and its exit from them
were altered by PMA. Decreased
exocytosis or recycling also contributed to the intracellular
accumulation of E-cadherin in PMA-treated cells. The recycling of
internalized E-cadherin was measured biochemically, first by
depletion of the internal biotinylated pool and second by trypsin
cleavage and recovery of a recycled, biotinylated ectodomain, and in
both cases we found that PMA caused a significant (~50%) reduction
in the rate of E-cadherin recycling. There was no evidence to suggest
that E-cadherin was being degraded in the presence of PMA; over the
periods tested, there was no net loss of biotinylated E-cadherin in
biochemical assays or of stained E-cadherin in cells. The depletion of
E-cadherin from endosomes was sensitive to Gö-6850, implicating
PKC in the exocytic step of E-cadherin recycling. In other cases,
phorbol esters are capable of altering the fate or routing of
endocytosed proteins, such as epidermal growth factor receptor, which
is diverted from a degradative to a recycling pathway by PKC activation
(7).
E-cadherin was localized in large, prominent vesicles in PMA-treated cells, and by confocal imaging these were found to be located mostly near the apical pole of the cell. The position of stained vesicles did not change in PMA-treated cells, suggesting that PMA increased the loading of the vesicles but did not reroute endocytosed E-cadherin to different compartments. Some of the vesicles in control cells and/or cells at 18°C (26) and those in PMA-treated cells (data not shown) also contain Rab 5 and are thus early endosomes. In MDCK cells, the appearance and apical position of the E-cadherin-labeled vesicles are consistent with the similarly positioned, apical recycling compartment that was first noted in studies tracking the transcytosis of polymeric immunoglobulin receptor (5, 8). This receptor accumulates in the recycling vesicles at 17°C (8), consistent with the 18°C accumulation of E-cadherin. The apical recycling compartment also receives transferrin receptor recycling from the basolateral membrane (5). As with previous findings (5, 8), E-cadherin in this compartment did not colocalize with fluid phase markers taken up from the apical membrane. We also found that PMA did not alter fluid phase uptake from the basolateral membrane in MDCK cells, as assessed by levels of FITC-dextran uptake. This is in agreement with previous results in MDCK cells (21) but differs from phorbol ester-induced fluid phase uptake in intestinal epithelial cells, which was found to occur at the apical, not basolateral, membrane (43). Thus E-cadherin is accumulated in an apical recycling compartment by PKC activation in MDCK cells, and the regulated accumulation of E-cadherin is selective, occurring without any increase in general membrane internalization.
That endocytosis and recycling are poised to regulate cell surface
adhesion events is now evident in several systems. Recent work showing
that there is regulated trafficking of 1-integrin on and
off the cell surface in mammary epithelial cells, and that this
controls cell spreading and motility (32), has close
parallels with the recycling of cadherins. Moreover,
1-integrin recycling is regulated by the expression and
activation of PKC-
(32). This provides an even stronger
basis for comparison with the regulation of E-cadherin recycling in
epithelial cells, which we show here is also mediated by PKCs, although
of a different class. Regulation of both pathways in and out of
endosomes allows cognate control of the level of surface-exposed
adhesive proteins by rapid movement off the cell surface or out of a
recycling compartment. The permeability of endothelial layers in
culture is regulated by PKC by being coupled to the internalization of
cadherin-based junctions (4). PKC and other regulators
might be expected to have their most dynamic and important roles in
epithelia during morphogenesis (44), where the levels of
surface-cadherin recycling are more active, as they are in preconfluent
cells (26). PKC did not unduly affect adhesion or polarity
in MDCK cell monolayers in our experiments because of the short
treatment times and the relative stability of cadherins in the adherens
junctions of fully confluent cells.
PKC has many possible downstream effectors and targets for
phosphorylation. Both cadherins and catenins themselves have
consensus phosphorylation sites, and serine/threonine phosphorylation
of cadherins has a role in regulating its adhesive function
(35). However, in many cases the effects of PKC on
endocytosis of receptors have been shown to be independent of the
phosphorylation of the receptors themselves (10, 13). The
actin cytoskeleton is a common target for activated PKC, which is able
to modulate actin assembly, either directly or via the phosphorylation
of actin-assembly proteins such as myristoylated alanine-rich C kinase
substrate (MARCKS) (19). The cadherin-catenin
complex at the adherens junction is tightly coupled, via -catenin,
to F-actin in the cortical web. The PKC regulation of actin dynamics
could be involved in E-cadherin trafficking in two ways, first by
modulating the association of the cadherin-catenin complex with F-actin
and second by controlling actin in one of its several purported roles
as part of the endocytosis machinery (reviewed in Ref.
36).
Our data suggest that depolymerization of F-actin and dissociation of E-cadherin from F-actin could both occur as part of the PMA response. Cytochalasin enhanced the uptake of surface E-cadherin, whereas stabilization of F-actin with Jas was able to significantly abrogate the PMA-induced uptake of E-cadherin; these two effects together suggest that the dynamic disassembly of actin occurs and is required for E-cadherin trafficking. Jas had no effect on endocytosis by itself, consistent with previous studies in MDCK cells from our laboratory (42). Finally, the diminished amount of actin coprecipitated with E-cadherin together with the bulk shift of E-cadherin to a detergent-soluble status are indications that some dissociation of E-cadherin from cortical actin also occurs in response to PMA. Other studies have also provided evidence linking cadherin trafficking to actin dynamics. In response to low calcium, keratinocytes internalize E-cadherin into large perinuclear structures, and this uptake was increased by expression of constitutively active Rac1, which concomitantly decreased cell-cell contact (3). Rac1 and Rho A mutants have also been shown to modulate the coendocytosis of the growth factor receptor c-met and E-cadherin (22).
Our data establish that the movement of surface E-cadherin in a physiological recycling pathway is indeed regulated. It is clear, for the first time, that the movements of E-cadherin into and out of an apical recycling endosomal compartment in MDCK cells are both regulated events and, as such, offer potential for regulating cadherin-based functions. Activation of novel class PKC(s) is implicated in this trafficking of E-cadherin. Regulation of F-actin stability and E-cadherin trafficking via PKC potentially allows for simultaneous regulation of cell-cell contact, cell motility, and growth in response to growth factor signaling.
![]() |
ACKNOWLEDGEMENTS |
---|
The authors thank Juliana Venturato for assistance with cell culture and members of the Stow laboratory for helpful discussions. We thank various colleagues for providing antibodies, and we thank Trevor Biden for helpful comments and suggestions.
![]() |
FOOTNOTES |
---|
This work was supported by grant and fellowship funding from the National Health and Medical Research Council (NHMRC) to J. L. Stow and by funding to A. S. Yap from the NHMRC and a Wellcome Trust Senior Research Fellowship. This work was also supported by funding from the Australian Research Council as part of the Special Research Center for Functional and Applied Genomics.
Address for reprint requests and other correspondence: J. L. Stow, Inst. for Molecular Biosciences, Univ. of Queensland, Brisbane, 4072 QLD, Australia (E-mail: j.stow{at}imb.uq.edu.au).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
March 20, 2002;10.1152/ajpcell.00566.2001
Received 27 November 2001; accepted in final form 14 March 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Adams, CL,
Chen YT,
Smith SJ,
and
Nelson WJ.
Mechanisms of epithelial cell-cell adhesion and cell compaction revealed by high-resolution tracking of E-cadherin-green fluorescent protein.
J Cell Biol
142:
1105-1119,
1998
2.
Adams, CL,
Nelson WJ,
and
Smith SJ.
Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion.
J Cell Biol
135:
1899-1911,
1996[Abstract].
3.
Akhtar, N,
and
Hotchin NA.
RAC1 regulates adherens junctions through endocytosis of E-cadherin.
Mol Biol Cell
12:
847-862,
2001
4.
Alexander, JS,
Jackson SA,
Chaney E,
Kevil CG,
and
Haselton FR.
The role of cadherin endocytosis in endothelial barrier regulation: involvement of protein kinase C and actin-cadherin interactions.
Inflammation
22:
419-433,
1998[ISI][Medline].
5.
Apodaca, G,
Katz LA,
and
Mostov KE.
Receptor-mediated transcytosis of IgA in MDCK cells is via apical recycling endosomes.
J Cell Biol
125:
67-86,
1994[Abstract].
6.
Asakura, T,
Nakanishi H,
Sakisaka T,
Takahashi K,
Mandai K,
Nishimura M,
Sasaki T,
and
Takai Y.
Similar and differential behaviour between the nectin-afadin-ponsin and cadherin-catenin systems during the formation and disruption of the polarized junctional alignment in epithelial cells.
Genes Cells
4:
573-581,
1999
7.
Bao, J,
Alroy I,
Waterman H,
Schejter ED,
Brodie C,
Gruenberg J,
and
Yarden Y.
Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome.
J Cell Biol
275:
26178-26186,
2000.
8.
Barroso, M,
and
Sztul ES.
Basolateral to apical transcytosis in polarized cells is indirect and involves BFA and trimeric G protein sensitive passage through the apical endosome.
J Cell Biol
124:
83-100,
1994[Abstract].
9.
Braga, VMM,
Del Maschio A,
Machesky L,
and
Dejana E.
Regulation of cadherin function by Rho and Rac: modulation by junction maturation and cellular context.
Mol Biol Cell
10:
9-22,
1999
10.
Cardone, MH,
Smith BL,
Song W,
Mochly-Rosen D,
and
Mostov KE.
Phorbol myristate acetate-mediated stimulation of transcytosis and apical recycling in MDCK cells.
J Cell Biol
124:
717-727,
1994[Abstract].
11.
Castagna, M,
Takai Y,
Kaibuchi K,
Sano K,
Kikkawa U,
and
Nishizuka Y.
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.
J Biol Chem
257:
7847-7851,
1982
12.
Eaton, S,
Auvinen P,
Luo L,
Jan YN,
and
Simons K.
CDC42 and Rac1 control different actin-dependent processes in the Drosophila wing disc epithelium.
J Cell Biol
131:
151-164,
1995[Abstract].
13.
Eichholtz, T,
Vossebeld P,
van Overveld M,
and
Ploegh H.
Activation of protein kinase C accelerates internalization of transferrin receptor but not of major histocompatibility complex class I, independent of their phosphorylation status.
J Biol Chem
267:
22490-22495,
1992
14.
Gekeler, V,
Boer R,
Uberall F,
Ise W,
Schubert C,
Utz I,
Hofmann J,
Sanders KH,
Schachtele C,
Klemm K,
and
Grunicke H.
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Br J Cancer
74:
897-905,
1996[ISI][Medline].
15.
Graeve, L,
Drickamer K,
and
Rodriguez-Boulan E.
Functional expression of the chicken liver asialoglycoprotein receptor in the basolateral surface of MDCK cells.
J Cell Biol
109:
2909-2816,
1989.
16.
Gumbiner, BM.
Epithelial morphogenesis.
Cell
69:
385-387,
1992[ISI][Medline].
17.
Gumbiner, BM.
Regulation of cadherin adhesive activity.
J Cell Biol
148:
399-404,
2000
18.
Hall, A.
Rho GTPases and the actin cytoskeleton.
Science
279:
509-514,
1998
19.
Hartwig, JH,
Thelen M,
Rosen A,
Jamney PA,
Nairn AC,
and
Aderem A.
MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin.
Nature
356:
618-622,
1992[ISI][Medline].
20.
Hirohashi, S.
Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.
Am J Pathol
153:
333-339,
1998
21.
Holm, PK,
Eker P,
Sandvig K,
and
van Deurs B.
Phorbol myristate acetate selectively stimulates apical endocytosis via protein kinase C in polarized MDCK cells.
Exp Cell Res
217:
157-168,
1995[ISI][Medline].
22.
Kamei, T,
Matozaki T,
Sakisaka T,
Kodama A,
Yokoyama S,
Peng YF,
Nakano K,
Takaishi K,
and
Takai Y.
Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells: regulation by Rho, Rac and Rab small G proteins.
Oncogene
18:
6776-6784,
1999[ISI][Medline].
23.
Kartenbeck, J,
Schmelz M,
Franke WW,
and
Geiger B.
Endocytosis of junctional cadherins in bovine kidney epithelial (MBCK) cells cultured in low Ca2+ ion medium.
J Cell Biol
113:
881-892,
1991[Abstract].
24.
Keenan, C,
and
Kelleher D.
Protein kinase C and the cytoskeleton.
Cell Signal
10:
225-232,
1998[ISI][Medline].
25.
Knudsen, KA,
Soler AP,
Johnson KR,
and
Wheelock MJ.
Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesin complex via alpha-catenin.
J Cell Biol
130:
67-77,
1995[Abstract].
26.
Le, TL,
Yap AS,
and
Stow JL.
Recycling of E-cadherin: a potential mechanism for regulating cadherin dynamics.
J Cell Biol
146:
219-232,
1999
27.
Lennartz, MR.
Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis.
Int J Biochem Cell Biol
31:
415-430,
1999[ISI][Medline].
28.
Martiny-Baron, G,
Kazanietz M,
Mischak H,
Blumberg P,
Kochs G,
Hug H,
Marme D,
and
Schachtele C.
Selective inhibition of protein kinase C isozymes by the indolocarbazole Go6976.
J Biol Chem
268:
9194-9197,
1993
29.
Miller, JR,
and
McClay DR.
Characterization of the role of cadherin in regulating cell adhesion during sea urchin development.
Dev Biol
192:
323-339,
1997[ISI][Medline].
30.
Newton, AC.
Protein kinase C: structure, function and regulation.
J Biol Chem
270:
28495-28498,
1995
31.
Newton, AC.
Regulation of protein kinase C.
Curr Opin Cell Biol
9:
161-167,
1997[ISI][Medline].
32.
Ng, T,
Shima D,
Squire A,
Bastiaens PI,
Gschmeissner S,
Humphries MJ,
and
Parker PJ.
PKCalpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic.
EMBO J
18:
3909-3923,
1999
33.
Ozawa, M,
Baribault H,
and
Kemler R.
The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species.
EMBO J
8:
1711-1717,
1989[Abstract].
34.
Ozawa, M,
and
Kemler R.
Molecular organization of the uvomorulin-catenin complex.
J Cell Biol
116:
989-996,
1992[Abstract].
35.
Provost, ERD
Controversies at the cytoplasmic face of the cadherin-based adhesion complex.
Curr Opin Cell Biol
11:
567-572,
1999[ISI][Medline].
36.
Qualmann, B,
Kessels MM,
and
Kelly RB.
Molecular links between endocytosis and the actin cytoskeleton.
J Cell Biol
150:
F111-F116,
2000[ISI][Medline].
37.
Ridley, AJ.
Rho-related proteins: actin cytoskeleton and cell cycle.
Curr Opin Genet Dev
5:
24-30,
1995[Medline].
38.
Rimm, DL,
Koslov ER,
Kebriaei P,
and
Cianci CD.
1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex.
Proc Natl Acad Sci USA
92:
8813-8817,
1995[Abstract].
39.
Shapiro, L,
Fannon AM,
Kwong PD,
Thompson A,
Lehmann MS,
Grubel G,
Legrand JF,
Als-Nielsen J,
Colman DR,
and
Hendrickson WA.
Structural basis of cell-cell adhesion by cadherins.
Nature
374:
306-307,
1995[ISI][Medline].
40.
Shore, EM,
and
Nelson WJ.
Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells.
J Cell Biol
266:
19672-19680,
1991.
41.
Shurety, W,
Bright NA,
and
Luzio JP.
The effects of cytochalasin D and phorbol myristate acetate on the apical endocytosis of ricin in polarised Caco-2 cells.
J Cell Sci
109:
2927-2935,
1996
42.
Shurety, W,
Stewart NL,
and
Stow JL.
Fluid-phase markers in the basolateral endocytic pathway accumulate in response to the actin assembly-promoting drug Jasplakinolide.
Mol Biol Cell
9:
957-975,
1998
43.
Song, JC,
Hrnjez BJ,
Farokhzad OC,
and
Matthews JB.
PKC-epsilon regulates basolateral endocytosis in human T84 intestinal epithelia: role of F-actin and MARCKS.
Am J Physiol Cell Physiol
277:
C1239-C1249,
1999
44.
Takeichi, M.
Cadherin cell adhesion receptors as a morphogenetic regulator.
Science
251:
1451-1455,
1991[ISI][Medline].
45.
Wenzel-Seifert, K,
Schachtele C,
and
Seifert R.
N-protein kinase C isozymes may be involved in the regulation of various neutrophil functions.
Biochem Biophys Res Commun
200:
1536-1543,
1994[ISI][Medline].
46.
Yap, AS,
Brieher WM,
and
Gumbiner BM.
Molecular and functional analysis of cadherin-based adherens junctions.
Annu Rev Cell Dev Biol
13:
119-146,
1997[ISI][Medline].
47.
Yap, AS,
Brieher WM,
Pruschy M,
and
Gumbiner BM.
Lateral clustering of the adhesive ectodomain: a fundamental determinant of cadherin function.
Curr Biol
7:
308-315,
1997[ISI][Medline].